Departamento de Medicina Física y Rehabilitación, Hidrología Médica, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España; Fundación MHG, Guadarrama, Madrid, España.
Servicio de Neurología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España.
Med Clin (Barc). 2019 Jan 18;152(2):55-58. doi: 10.1016/j.medcli.2018.02.015. Epub 2018 Apr 19.
Hippotherapy is being used as a promising method in the physical treatment of multiple sclerosis (MS).
Comparative open clinical pre-post study into hippotherapy intervention during a 6-month period in patients with MS (n=6). Not randomised and with control group (n=4). The study was performed by MHG Foundation.
A statistically significant improvement was observed in the therapy group in: spasticity pre-post measured by the modified Ashworth scale (P=.01). Statistically significant improvement in fatigue impact (P<.0001) measured with FIS; in general, perception of heath outcome in urinary quality of life scale KHQ (P=.033), and in subscales 2, 3 and 4 of MSQOL-54 (P=.011). Control group showed no improvement in any scale.
This study reinforces current literature that supports hippotherapy as an adequate intervention for MS patients. Further studies with more participants, control groups and blinded research would be logical steps for future research in this field.
骑马疗法作为一种有前途的方法，正在被用于多发性硬化症（MS）的物理治疗中。
对 MS 患者进行为期 6 个月的骑马疗法干预的比较开放临床前后研究（n=6）。非随机对照研究，设有对照组（n=4）。该研究由 MHG 基金会进行。
治疗组在以下方面观察到统计学上的显著改善：改良 Ashworth 量表测量的痉挛程度（P=.01）；疲劳影响（FIS）的显著改善（P<.0001）；一般健康状况在尿生活质量量表 KHQ 中的感知（P=.033），以及在 MSQOL-54 的子量表 2、3 和 4 中（P=.011）。对照组在任何量表上均无改善。
这项研究加强了当前支持骑马疗法作为 MS 患者适当干预措施的文献。未来在该领域的研究中，进一步增加参与者、对照组和盲法研究将是合乎逻辑的步骤。
